More specifically, the highest number of patients with IDH1 mutation in tissue was found in the anaplastic astrocytoma group (38.1%), following by diffuse astrocytoma (23.8%), GBM (14.3%), oligodendroglioma (14.3%), and oligoastrocytoma (9.5%). Here, IDH1 is linked to oligoastrocytoma.